News
Important Only
Vision Marine Technologies Announces Reverse Stock Split
Jan 12 (Reuters) - Vision Marine Technologies Inc VMAR.O:VISION MARINE TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLITVISION MARINE TECHNOLOGIES INC - ANNOUNCES 1-FOR-40 REVERSE STOCK SPLITVISION MARINE TECHNOLOGIES INC - REVERSE STOCK SPLIT EFFECTIVE JANUARY 14, 2026Reuters
11 minutes ago
Visionwave Holdings Announces Formation Of Technology Platform Joint Venture To Propel Defense, Secure Systems, And Quantum-Enhanced Ip Leadership
Jan 12 (Reuters) - VisionWave Holdings Inc VWAV.O:VISIONWAVE HOLDINGS ANNOUNCES FORMATION OF TECHNOLOGY PLATFORM JOINT VENTURE TO PROPEL DEFENSE, SECURE SYSTEMS, AND QUANTUM-ENHANCED IP LEADERSHIPReuters
13 minutes ago
Allegiant Travel Co - Enters Merger Agreement With Sun Country Airlines - SEC Filing
Jan 12 (Reuters) - Allegiant Travel Co ALGT.O:ALLEGIANT TRAVEL CO - ENTERS MERGER AGREEMENT WITH SUN COUNTRY AIRLINES - SEC FILINGALLEGIANT TRAVEL: TO PAY SUN COUNTRY A TERMINATION FEE OF $52.2 MILLION CONVERSELY IF MERGER AGREEMENT TERMINATED UNDER CERTAIN CIRCUMSTANCESALLEGIANT TRAVEL: SUN COUNTRY...Reuters
13 minutes ago
Turn Therapeutics Announces Corporate And Pipeline Updates And 2026 Outlook Ahead Of The 44Th Annual J.P. Morgan Healthcare Conference
Jan 12 (Reuters) - Turn Therapeutics Inc TTRX.O:TURN THERAPEUTICS ANNOUNCES CORPORATE AND PIPELINE UPDATES AND 2026 OUTLOOK AHEAD OF THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCEReuters
16 minutes ago
Arcutis Highlights 2026 Strategic Priorities And Anticipated Milestones
Jan 12 (Reuters) - Arcutis Biotherapeutics Inc ARQT.O:ARCUTIS HIGHLIGHTS 2026 STRATEGIC PRIORITIES AND ANTICIPATED MILESTONESARCUTIS BIOTHERAPEUTICS INC - TOPLINE RESULTS FROM INTEGUMENT-INFANT PHASE 2 STUDY EXPECTED Q1 2026Reuters
16 minutes ago
Health tech firm Hyperfine prelim Q4 revenue rises 127% on Swoop system adoption
OverviewHealth tech firm's preliminary Q4 revenue rises 127% yr/yr, driven by Swoop system adoptionPreliminary Q4 net cash burn down 30% yr/yrCompany exits 2025 with approximately $35 mln in cash and equivalentsOutlookHyperfine to provide full 2025 results and 2026 outlook in March 2026 earnings...Reuters
17 minutes ago
Biolife Solutions Announces Preliminary Fourth Quarter And Full Year 2025 Unaudited Revenue From Continuing Operations
Jan 12 (Reuters) - BioLife Solutions Inc BLFS.O:BIOLIFE SOLUTIONS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 UNAUDITED REVENUE FROM CONTINUING OPERATIONSQ4 UNAUDITED REVENUE FROM CONTINUING OPERATIONS OF $24.8 MILLIONQ4 REVENUE VIEW $24.1 MILLION -- LSEG IBES DATAFurther company coverag...Reuters
17 minutes ago
Erasca Inc - Reports Promising Early Clinical Data For ERAS-0015
Jan 12 (Reuters) - Erasca Inc ERAS.O:ERASCA INC - REPORTS PROMISING EARLY CLINICAL DATA FOR ERAS-0015ERASCA INC - PLANS PHASE 1 DATA RELEASE FOR ERAS-0015 AND ERAS-4001 IN 2026ERASCA INC - REPORTS FAVORABLE SAFETY AND TOLERABILITY FOR ERAS-0015ERASCA INC - PLANS PHASE 1 DATA FOR KRAS-MUTANT TUMORS I...Reuters
18 minutes ago
U.S. RESEARCH ROUNDUP-American Express, Ameriprise Financial, Mastercard
Jan 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including American Express Co, Ameriprise Financial and Mastercard, on Monday. HIGHLIGHTS American Express Co AXP.N: JP Morgan raises target price to $38...Reuters
19 minutes ago
Kyverna Therapeutics Inc - Appoints Christi Shaw As Executive Chairperson - SEC Filing
Jan 12 (Reuters) - Kyverna Therapeutics Inc KYTX.O:KYVERNA THERAPEUTICS INC - APPOINTS CHRISTI SHAW AS EXECUTIVE CHAIRPERSON - SEC FILINGKYVERNA THERAPEUTICS INC - IAN CLARK TO REMAIN AS BOARD MEMBER - SEC FILINGReuters
19 minutes ago
Abercrombie & Fitch tempers annual sales growth forecast
Jan 12 (Reuters) - Abercrombie & Fitch ANF.N lowered its annual net sales growth forecast on Monday, sending shares down 16% in premarket trade.The company expects full-year net sales growth of at least 6% compared to its previous forecast of a rise between 6% and 7%.Reuters
22 minutes ago
Heineken's returns under van den Brink among worst of departing consumer CEOs
By Paolo Laudani Jan 12(Reuters) - Heineken HEIN.AS chief executive Dolf van den Brink resigned on Monday after six years of leading the Dutch brewer, the latest of several changes at the top of leading consumer companies over the last 18 months. A Reuters analysis of companies that ...Reuters
23 minutes ago
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, And Upcoming Nxt-41X Milestones
Jan 12 (Reuters) - Elutia Inc ELUT.O:ELUTIA REPORTS PRELIMINARY FOURTH QUARTER 2025 RESULTS, STRENGTHENED FINANCIAL POSITION, AND UPCOMING NXT-41X MILESTONESELUTIA INC - ANTICIPATES FDA CLEARANCE FOR NXT-41X IN 2027Reuters
24 minutes ago
American Eagle Outfitters Inc - Raises Q4 Operating Income Outlook To $167-$170 Million
Jan 12 (Reuters) - American Eagle Outfitters Inc AEO.N:AMERICAN EAGLE OUTFITTERS INC - RAISES Q4 OPERATING INCOME OUTLOOK TO $167-$170 MILLIONAMERICAN EAGLE OUTFITTERS INC: Q4-TO-DATE COMPARABLE SALES, THROUGH SATURDAY, JANUARY 3, 2026, ARE UP IN HIGH SINGLE DIGITSReuters
24 minutes ago
Nuvation Bio Reports Preliminary Fourth Quarter And Full Year 2025 Financial Results And Provides 2026 Outlook Ahead Of 44Th Annual J.P. Morgan Healthcare Conference
Jan 12 (Reuters) - Nuvation Bio Inc NUVB.N:NUVATION BIO REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES 2026 OUTLOOK AHEAD OF 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCENUVATION BIO INC - PRELIM IBTROZI NET PRODUCT REVENUE $15.7 MILLION IN Q4Reuters
24 minutes ago
Kyivstar launches first 5G pilot in Lviv as Ukraine enters fifth year of war
By Leo Marchandon and Dan PeleschukKYIV, Jan 12 (Reuters) - Kyivstar KYIV.O has launched a 5G test zone in the city of Lviv, marking the company's first local 5G pilot in Ukraine as it seeks to advance infrastructure development across the country entering its fifth year of war with Russia.The t...Reuters
25 minutes ago
Atricure Inc - Enters First Amendment To Credit Agreement - SEC Filing
Jan 12 (Reuters) - AtriCure Inc ATRC.O:ATRICURE INC - ENTERS FIRST AMENDMENT TO CREDIT AGREEMENT - SEC FILINGATRICURE INC - FIRST AMENDMENT PROVIDES THREE-YEAR EXTENSION OF CREDIT AGREEMENT - SEC FILINGSource text: [ID:n0001193125-26-009814]Reuters
25 minutes ago
Rigel Pharmaceuticals prelim Q4 revenue beats estimates
OverviewBiotechnology firm's preliminary Q4 revenue beats analyst expectationsNet product sales for Q4 expected to be $65.4 million, grew compared to the same period last yearCompany anticipates positive net income for full year 2026OutlookRigel anticipates 2026 total revenue of $275 to $290 ml...Reuters
25 minutes ago
The Oncology Institute Reaffirms 2025 Guidance And Provides Preliminary 2026 Outlook
Jan 12 (Reuters) - Oncology Institute Inc TOI.O:THE ONCOLOGY INSTITUTE REAFFIRMS 2025 GUIDANCE AND PROVIDES PRELIMINARY 2026 OUTLOOKONCOLOGY INSTITUTE INC - ANTICIPATES 2026 REVENUE BETWEEN $630 MILLION AND $650 MILLIONONCOLOGY INSTITUTE INC: LOOKING BEYOND 2026, CO IS WELL POSITIONED FOR CONTINUED ...Reuters
26 minutes ago
